Insider Transactions in Q1 2022 at Greenwich Life Sciences, Inc. (GLSI)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 11
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
5,500
+0.45%
|
$104,500
$19.8 P/Share
|
|
Feb 04
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.42%
|
$95,000
$19.59 P/Share
|
|
Jan 31
2022
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
500
+0.2%
|
$9,000
$18.47 P/Share
|
|
Jan 21
2022
|
Kenneth Hallock Director |
BUY
Open market or private purchase
|
Direct |
300
+0.08%
|
$4,800
$16.32 P/Share
|
|
Jan 21
2022
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
500
+0.2%
|
$8,000
$16.33 P/Share
|
|
Jan 18
2022
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
500
+0.2%
|
$9,000
$18.87 P/Share
|
|
Jan 13
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.08%
|
$19,000
$19.99 P/Share
|
|
Jan 13
2022
|
Frank Joseph Daugherty Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.11%
|
$19,000
$19.99 P/Share
|
|
Jan 13
2022
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
1,000
+0.39%
|
$19,000
$19.99 P/Share
|
|
Jan 03
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,050
+0.17%
|
$47,150
$23.82 P/Share
|